SBCOLD & SBCOLD-DS SYRUP 60ML Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SBCOLD / SBCOLD-DS
SBCOLD :- Each 5 ml contains : Cetirizine 1mg + Phenylephrine 2.5mg + Paracetamol 125mg SBCOLD-DS :- Cetirizine 2mg + Phenylephrine 2.5mg + Paracetamol 250mg
SBCOLD & SBCOLD-DS SYRUP 60ML (SBCOLD :- Each 5 ml contains : Cetirizine 1mg + Phenylephrine 2.5mg + Paracetamol 125mg SBCOLD-DS :- Cetirizine 2mg + Phenylephrine 2.5mg + Paracetamol 250mg) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in SBCOLD & SBCOLD-DS SYRUP 60ML deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C. Do not freeze. Keep container tightly closed.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SBCOLD / SBCOLD-DS features SBCOLD :- Each 5 ml contains : Cetirizine 1mg + Phenylephrine 2.5mg + Paracetamol 125mg SBCOLD-DS :- Cetirizine 2mg + Phenylephrine 2.5mg + Paracetamol 250mg prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Tracked for therapeutic compliance for SBCOLD & SBCOLD-DS SYRUP 60ML
SBCOLD & SBCOLD-DS SYRUP 60ML has been tracked for therapeutic compliance across diverse adult cohorts, with attending physicians reporting swift symptom reduction across outpatients. The secondary carton board quality is heavy and durable, protecting contents from transport shock. Zero supply interruptions and consistent batch quality make this a standout pharmaceutical line.
Questions Regarding SBCOLD / SBCOLD-DS
What is the therapeutic indication and composition of SBCOLD & SBCOLD-DS SYRUP 60ML?
SBCOLD & SBCOLD-DS SYRUP 60ML contains SBCOLD :- Each 5 ml contains : Cetirizine 1mg + Phenylephrine 2.5mg + Paracetamol 125mg SBCOLD-DS :- Cetirizine 2mg + Phenylephrine 2.5mg + Paracetamol 250mg indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for SBCOLD & SBCOLD-DS SYRUP 60ML?
SBCOLD & SBCOLD-DS SYRUP 60ML is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SBCOLD & SBCOLD-DS SYRUP 60ML?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBCOLD & SBCOLD-DS SYRUP 60ML along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SBCOLD & SBCOLD-DS SYRUP 60ML is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
